Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

• Hauptverfasser: Paola Orlandi (Verfasst von), Anna Solini (Verfasst von), Marta Banchi (Verfasst von), Maurizia Rossana Brunetto (Verfasst von), Dania Cioni (Verfasst von), Lorenzo Ghiadoni (Verfasst von), Guido Bocci (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2021-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Non-alcoholic fatty liver disease is the most common liver disorder worldwide, and its progressive form non-alcoholic steatohepatitis (NASH) is a growing cause of liver cirrhosis and hepatocellular carcinoma (HCC). Lifestyle changes, which are capable of improving the prognosis, are hard to achieve,...